Comparison of Gemcitabine v. Gemcitabine Plus Docetaxel in Unresectable Soft Tissue Sarcoma

Clinical trial NCT00142571 · COMPLETED

Trial details

NCT number: NCT00142571
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Sarcoma, Soft Tissue

Start date: 2003-01-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.